Vontobel Holding
BBIO icon

Vontobel Holding’s BridgeBio Pharma BBIO Stock Holding History

Vontobel Holding’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.63M Buy
35,363
+17,491
+98% +$1.23M 0.01% 582
2026
Q1 		$1.33M Sell
17,872
-1,190
-6% -$86.3K ﹤0.01% 592
2025
Q4 		$1.46M Buy
19,062
+8,620
+83% +$566K ﹤0.01% 654
2025
Q3 		$542K Buy
10,442
+612
+6% +$29.8K ﹤0.01% 920
2025
Q2 		$424K Buy
+9,830
New +$358K ﹤0.01% 948
2024
Q2 		– Sell
-30,216
Closed -$934K – 1080
2024
Q1 		$934K Sell
30,216
-595
-2% -$20.2K 0.01% 605
2023
Q4 		$1.24M Sell
30,811
-35,546
-54% -$1.07M 0.01% 540
2023
Q3 		$1.75M Sell
66,357
-1,202
-2% -$34.1K 0.02% 455
2023
Q2 		$1.16M Sell
67,559
-25,161
-27% -$379K 0.01% 561
2023
Q1 		$1.54M Sell
92,720
-12,858
-12% -$150K 0.01% 481
2022
Q4 		$805K Buy
+105,578
New +$1.01M 0.01% 630

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Vontobel Holding's BBIO Position: Q2 2026 in Review

Vontobel Holding increased its BridgeBio Pharma (BBIO) stake by 98% in Q2 2026, buying an estimated $1.23M and bringing the position to 35,363 shares worth $2.63M. The position accounts for 0.01% of the portfolio, ranked #582.

Vontobel Holding first reported a position in BBIO in Q4 2022 and has held it in 11 quarters since. 475 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Vontobel Holding held 35,363 shares of BridgeBio Pharma worth $2.63M as of Q2 2026.
  • Vontobel Holding bought 17,491 BridgeBio Pharma shares in Q2 2026, an estimated $1.23M.
  • BridgeBio Pharma made up 0.01% of Vontobel Holding's portfolio in Q2 2026, its #582 holding.
  • Vontobel Holding first reported a position in BridgeBio Pharma in Q4 2022 and has held it in 11 quarters since.
  • 475 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.